Snehal Patel is the Executive Vice President and Head of Technical Operations at Sana Biotechnology. He has oversight of Process and Analytical Development, Manufacturing, Supply Chain, CMC Regulatory, and Technical Quality for Cell and Gene Therapy. Snehal has a breadth of knowledge and experience in leading roles in Manufacturing, Technology, Supply Chain, and Quality Assurance in Biologics, Small Molecules, and most recently in Cell Therapy.
Prior to Sana, Snehal was the Global Head for Cell Therapy Manufacturing at Bristol Myers Squibb (BMS). He led the growing global manufacturing network to produce Clinical and Commercial Cell Therapy Products, including two cell therapies commercially launched in 2021 by BMS. Prior to this role he served as Site Head for Cell Therapy Manufacturing in Bothell, Washington for Juno Therapeutics. Prior to Juno, Snehal worked at Genentech/Roche for 18 years, holding a variety of different roles with increasing responsibility, including Head of Global External Drug Product Manufacturing, Head of Drug Product Operations, and Head of Quality Operations.